---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-035889"
form_type: "8-K"
ticker: "OGEN"
cik: "0001174940"
company_name: "ORAGENICS INC"
filed_at: "2022-12-19T23:59:59+00:00"
generated_at: "2026-06-21T02:23:20.331760+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Oragenics terminates ATM program, appoints Charles Pope as Chairman

## Summary
- Terminated Sales Agreement with AGP for ATM program, effective Dec 29, 2022; no further share sales.
- In Q4 2022, sold 357,438 shares at avg $0.2024 per share via ATM prior to termination.
- Charles Pope appointed Chairman of Board; Frederick Telling steps down as Chairman but remains independent director.

## SEC filing metadata
- accession: 0001493152-22-035889
- form_type: 8-K
- ticker: OGEN
- cik: 0001174940
- company_name: ORAGENICS INC
- filed_at: 2022-12-19T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1174940/000149315222035889/0001493152-22-035889-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1174940/000149315222035889/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-035889
- JSON: https://secwatch.observer/filing/0001493152-22-035889.json
- Plain text: https://secwatch.observer/filing/0001493152-22-035889.txt

## Key facts
- Material Agreements
  ORAGENICS INC terminated Sales Agreement with A.G.P./Alliance Global Partners (effective 2022-12-19).
  - Action: termination
  - Agreement: atm program
  - Counterparty: A.G.P./Alliance Global Partners
  - Effective: 2022-12-19
  source text: On December 19, 2022, Oragenics, Inc. (the “Company”) sent written notice of termination to A.G.P./Alliance Global Partners ("AGP"), pursuant to the terms of the Company’s Sales Agreement with AGP in connection with the Company’s At-the-Market Sales Program (the “ATM Program”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1174940/000149315222035889/0001493152-22-035889-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.